Piperazinyl CCR1 antagonists--optimization of human liver microsome stability

Area of Science:

• Medicinal Chemistry
• Pharmacology

Background:

• The chemokine receptor 1 (CCR1) is implicated in various inflammatory and autoimmune diseases.
• Targeting CCR1 offers a potential therapeutic strategy for managing these conditions.

Purpose of the Study:

• To describe the synthesis of novel CCR1 antagonists.
• To evaluate the biological activity of these compounds.
• To characterize their pharmacokinetic profiles.

Main Methods:

• Chemical synthesis of novel antagonist compounds.
• In vitro assays to assess receptor binding and functional antagonism.
• In vivo studies to determine pharmacokinetic parameters (absorption, distribution, metabolism, excretion).

Main Results:

• Successful synthesis of a series of potent and selective CCR1 antagonists.
• Demonstrated significant inhibition of CCR1-mediated cellular responses in vitro.
• Established favorable pharmacokinetic profiles, indicating good oral bioavailability and suitable half-life in preclinical models.

Conclusions:

• The novel CCR1 antagonists synthesized possess promising biological activity and suitable pharmacokinetic properties.
• These compounds represent potential drug candidates for the treatment of CCR1-mediated diseases.